MK
Mahesh Kondam
About Mahesh Kondam
Data last updated:
Mahesh Kondam is a Director at Vilo Speciality Pharma Private Limited (since 2026), Director at Axia Pharma Private Limited (since 2026) and Director at Oncosynth Pharma Private Limited (since 2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vilo Speciality Pharma Private Limited U46497TS2026PTC219873 | Director | 23 Jul 2026 | 2026 | Active | |
| Axia Pharma Private Limited U21001TS2026PTC219538 | Director | 16 Jul 2026 | 2026 | Active | |
| Oncosynth Pharma Private Limited U21001TS2026PTC216088 | Director | 13 May 2026 | 2026 | Active |
Board colleagues of Mahesh Kondam
| Name | DIN | Company | Designation |
|---|---|---|---|
| Madhusudhan Yadamakanti Reddy | 02874260 | Vilo Speciality Pharma Private Limited , Axia Pharma Private Limited | Non- Individual Subscriber |
| U21001ts2026ptc219538 U21001ts2026ptc219538 | Axia Pharma Private Limited | Company/Llp | |
| Durga Kishore Pabbanidi | 11045613 | Oncosynth Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mahesh Kondam
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mahesh Kondam
Mahesh Kondam currently holds 3 directorships: Vilo Speciality Pharma Private Limited (Director, since 23 Jul 2026); Axia Pharma Private Limited (Director, since 16 Jul 2026); Oncosynth Pharma Private Limited (Director, since 13 May 2026).
Mahesh Kondam was first appointed on 13 May 2026 as Director at Oncosynth Pharma Private Limited.
The current boards of Mahesh Kondam's companies include Madhusudhan Yadamakanti Reddy (Vilo Speciality Pharma Private Limited), U21001ts2026ptc219538 U21001ts2026ptc219538 (Axia Pharma Private Limited), Durga Kishore Pabbanidi (Oncosynth Pharma Private Limited).